Kalkulaator Bio Protocol kuni Brasiilia reaal
Muuda lihtsalt Bio Protocol Brasiilia reaal-ks meie kalkulaatoriga. Tutvu konversiooni arenguga ja peamiste vastavustega BIO ja BRL vahel.
Krüptovaluutade konverter
Bio Protocol - BRL — Turuandmed
Turu kapitalisatsioon
R$343,81M
24h maht
R$108,66M
Maksimaalne pakkumine
3,32B
Käibes olev pakkumine
3,32B
Tüüp
currency
Hind BIO/BRL - Bio Protocol/Euro
Bio Protocol hind on tõusnud
Bio Protocol väärtus on R$0,1623. See tähendab, et 5 BIO ostmiseks pead maksma R$0,8114. Vastupidi, R$1,00 abil saad osta kokku 6,16237314 BIO, samas kui R$50,00 võimaldaks sul soetada 308,11865698 BIO.
Viimase 7 päeva jooksul on Bio Protocol hind kasvanud +7,28%. Samas, viimase 24 tunni jooksul on hind muutunud +5,27%.
BIO konversioon BRL
| Kogus | 03.07.2026, 23:58 |
|---|---|
| 0.5 BIO | R$0,0811 |
| 1 BIO | R$0,1623 |
| 2 BIO | R$0,3246 |
| 5 BIO | R$0,8114 |
| 10 BIO | R$1,62 |
| 50 BIO | R$8,11 |
| 100 BIO | R$16,23 |
| 500 BIO | R$81,14 |
| 1000 BIO | R$162,28 |
BRL konversioon BIO
| Kogus | 03.07.2026, 23:58 |
|---|---|
| R$0,5000 | 0.08113757 BIO |
| R$1,00 | 0.16227515 BIO |
| R$2,00 | 0.32455029 BIO |
| R$5,00 | 0.81137573 BIO |
| R$10,00 | 1.62275146 BIO |
| R$50,00 | 8.11375729 BIO |
| R$100,00 | 16.22751459 BIO |
| R$500,00 | 81.13757293 BIO |
| R$1.000,00 | 162.27514585 BIO |
Osta Bio Protocol turvaliselt
Registreeru Bit2Me-s ja pääse kõige usaldusväärsemale krüptovaluutade vahetusplatvormile, et osta ja müüa Bio Protocol turvaliselt.
Mis on Bio Protocol?
Bio Protocol is a platform designed to accelerate scientific development through the decentralised funding and management of biotechnological projects. Its aim is to enable global communities of scientists, patients, and investors to collaborate on the creation and shared ownership of new drugs and therapies through decentralised autonomous organisations specialised in biotechnology, known as BioDAOs. The native token of Bio Protocol, called BIO, fulfils essential functions within the ecosystem. In addition to facilitating transactions, it grants its holders governance rights, allowing them to influence key decisions such as the selection of BioDAOs to support and the allocation of resources for the development of intellectual property assets. This approach seeks to democratise scientific research and encourage active community participation in biotechnological innovation.
